Physician

Ahmad Azmi Kabbani, MD

According to 2025 Medicare claims, Ahmad Kabbani, MD (NPI: 1528328796) practices internal medicine in the Macon-Bibb County, GA market, with the plurality of this provider's patient population coming from Bibb, GA. This provider's primary affiliated billing organization is MACON MEDICAL GROUP PC (NPI: 1912914847; TIN: 58-2545719) and primary practice location at 31201-3206. Kabbani is affiliated with the TC2, LLC (ACO ID: A3365), participating under the MSSP model.

Kabbani's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,042 traditional Medicare patients, billed 14,604 HCPCS/CPT codes, and received $396,414 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 3,391 prescription claims across 582 beneficiaries totaling $867,642 in drug costs, led by Krystexxa (Pegloticase). DME data shows 164 claims. Open Payments data shows 93 records totaling $2,452. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $49,609 to $396,414. Similarly, Part D prescription costs have moved sharply higher in recent years, from $35,572 to $867,642. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	229	620	$49,609
2016	253	622	$51,015
2017	N/R	N/R	N/R
2018	451	3,470	$151,627
2019	865	18,975	$337,741
2020	908	12,947	$377,957
2021	942	13,107	$405,403
2022	889	11,067	$302,811
2023	965	13,264	$310,242
2024	1,042	14,604	$396,414

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	66	492	$35,572
2016	65	218	$8,143
2017	23	85	$3,479
2018	65	169	$7,902
2019	198	908	$57,572
2020	338	1,957	$539,274
2021	421	2,498	$834,751
2022	484	2,937	$892,892
2023	540	3,083	$777,536
2024	582	3,391	$867,642

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	13	$196
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	113	$4,637
2021	N/R	166	$3,955
2022	N/R	160	$2,812
2023	N/R	200	$2,946
2024	N/R	164	$2,001

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	767	1,199	$87
36415	Insertion of needle into vein for collection of blood sample	736	1,194	$9
80069	Kidney function blood test panel	728	1,179	$8
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	729	1,151	$8
81003	Automated urinalysis test	714	1,162	$2

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Krystexxa	Pegloticase	24	336	$680,671
Auryxia	Ferric Citrate	15	797	$51,072
Sevelamer Carbonate	Sevelamer Carbonate	46	2,248	$9,992
Clonidine	Clonidine	43	1,910	$6,416
Potassium Citrate Er	Potassium Citrate	28	1,950	$4,442

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7507	Tacrolimus, immediate release, oral, 1 mg	N	N/R	39	$620
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	34	$595
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	43	$552
J7517	Mycophenolate mofetil, oral, 250 mg	N	N/R	22	$217
J7512	Prednisone, immediate release or delayed release, oral, 1 mg	N	N/R	26	$17

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	93	$2,452	Amgen Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Ahmad Azmi Kabbani, MD?

Tedicare shows public-source Medicare data for Ahmad Azmi Kabbani, MD (NPI 1528328796), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ahmad Azmi Kabbani, MD have ACO affiliation data?

Ahmad Azmi Kabbani, MD is shown with ACO affiliation data for TC2, LLC (MSSP, ACO ID A3365).

What billing organization is linked to Ahmad Azmi Kabbani, MD?

Ahmad Azmi Kabbani, MD is linked to MACON MEDICAL GROUP PC (billing NPI 1912914847) in the available physician profile data.

Does Ahmad Azmi Kabbani, MD have Open Payments data?

Ahmad Azmi Kabbani, MD has 93 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.